Treasury Chief Rachel Reeves Aims for Focused Action on Bills in Forthcoming Budget

Chancellor Reeves has stated she is planning "specific measures to address cost of living pressures" in next month's financial statement.

In comments to the BBC, she stated that lowering inflation is a shared duty of both the government and the central bank.

The UK's price growth is expected to be the highest among the G7 advanced economies this calendar year and the following year.

Possible Energy Cost Interventions

It is understood the government could take action to bring down utility costs, for instance by reducing the present 5% level of value-added tax charged on energy.

An additional approach is to lower some of the regulatory levies currently included in household expenses.

Fiscal Constraints and Analyst Expectations

The government will obtain the latest report from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much room there is for these measures.

The view from the majority of experts is that the Chancellor will have to introduce tax rises or budget cuts in order to adhere to her voluntary debt limits.

Earlier on Thursday, estimates indicated there was a £22 billion shortfall for the chancellor to address, which is at the more modest range of projections.

"It is a shared job between the Bank of England and the government to further reduce some of the drivers of inflation," Reeves told reporters in Washington, at the yearly gatherings of the IMF and World Bank.

Revenue Pledges and International Issues

While a great deal of the attention has been on likely tax increases, the chancellor said the most recent figures from the OBR had not changed her commitment to manifesto promises not to raise tax levels on income tax, VAT or social security contributions.

She blamed an "uncertain world" with rising geopolitical and commercial tensions for the Budget tax moves, likely to be targeted on those "with the broadest shoulders."

Global Economic Tensions

Addressing apprehensions about the UK's commercial links with China she said: "The UK's national security invariably come first."

Last week's announcement by Chinese authorities to strengthen export controls on rare earths and other resources that are essential for advanced tech production led US President the US President to threaten an additional 100% tariff on imports from the Asian country, raising the prospect of an all-out trade war between the two economic giants.

The US Treasury Secretary called China's move "commercial pressure" and "a international production control attempt."

Asked about considering the American proposal to participate in its battle with China, the Chancellor said she was "extremely troubled" by Chinese actions and called on the Beijing authorities "not to put up barriers and limit trade."

She said the decision was "harmful for the international commerce and generates additional challenges."

"In my view there are fields where we must address China, but there are also significant chances to trade with China's economy, including financial services and other areas of the economy. We've got to achieve that balance appropriate."

The chancellor also affirmed she was working with G7 counterparts "on our own critical minerals strategy, so that we are more independent."

Health Service Medicine Costs and Investment

Reeves also admitted that the cost the National Health Service spends on pharmaceuticals could go up as a consequence of current talks with the Trump administration and its drugs companies, in exchange for reduced taxes and funding.

Some of the world's largest drug companies have said lately that they are either pausing or canceling operations in the United Kingdom, with some attributing the insufficient payments they are obtaining.

Last month, the government science advisor said the cost the NHS spends on drugs would have to rise to prevent businesses and drug research funding leaving the UK.

The Chancellor informed media: "It has been observed because of the payment system, that drug testing, innovative medicines have not been provided in the United Kingdom in the manner that they are in other European countries."

"We want to make sure that individuals getting treatment from the National Health Service are able to obtain the best life-saving drugs in the world. And so we are looking at this situation, and... seeking to obtain more capital into Britain."